![]() |
|
||||||||||
News ReleasesPDI, Inc. Announces Significant New Contract Sales Engagement with Top-10 Pharmaceutical CompanySADDLE RIVER, N.J., Mar 29, 2007 (BUSINESS WIRE) -- PDI, Inc. (Nasdaq: PDII), a provider of commercialization services to the biopharmaceutical industry, today announced that it has signed an agreement with a top-10 pharmaceutical company for a new contract sales engagement for a cardiology drug. The initiative will utilize PDI's exclusive Select Access team to reach primary care physicians and cardiologists. The contract, which will begin on April 2, 2007, is expected to generate approximately $13 million in revenue for PDI over its one-year term. Mr. Michael Marquard, PDI's CEO, commented, "The selection of PDI for this contract underscores our strategy to provide innovative on-demand solutions to meet the industry's growing need for flexible sales service offerings. We are very pleased to have been selected for this program and are excited about the opportunity to build our relationship with this important customer." Select Access is a unique selling model in which multiple, non-competitive clients can access a fully operational sales force with established physician relationships, in high potential zip codes, while providing each client with primary position calls approximately 80% of the time. Since the sales team, and its cost, are leveraged across multiple clients, Select Access is effective for established, seasonal, specialty prescription and over-the-counter products. Nancy Connelly, Senior Vice President and General Manager of Select Access, commented, "We believe that our track record of building and managing high-quality, results-oriented flex-time teams was particularly important in the selection of PDI. Select Access, the only leveraged sales team in the industry, is a powerful asset that can help our clients maximize their return on investment." About Select Access Select Access, a targeted sales solution for a diverse group of pharmaceutical products, leverages an existing infrastructure to maximize brand profitability. Rapid deployment and national coverage by approximately 350 experienced sales representatives in high prescribing territories increases speed to impact. Select Access™ is the only alternative sales force model that gives clients complete target audience control and flexibility and where the majority of sales calls are single detail. Select Access' unmatched value is perfectly aligned to increase incremental revenue for seasonal, established, and OTC brands, and for specialty brands that could gain an additional revenue stream from a primary care presence. About PDI PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its customers by providing strategic flexibility; sales, marketing and commercialization expertise; and a philosophy of performance. PDI operates in two areas, Sales Services and Marketing Services. Our Sales Services include our Performance Sales Teams(TM), which are dedicated teams for specific clients; and Select Access(TM), our targeted sales solution that leverages an existing infrastructure. Our Marketing Services include marketing research and consulting services through TVG in Dresher, PA., and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high-quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM(R)), located in Dresher, PA. PDI's experience extends across multiple therapeutic categories and includes office- and hospital-based initiatives. PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its customers. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to retaining the industry's highest-quality employees. For more information, please visit the Company's website at www.pdi-inc.com. For more information, visit the Company’s website at www.pdi-inc.com. For more information contact:
Copyright © Select Access, a division of PDI, Inc. • Information Privacy Policy About Select Access | Markets Served | Press & Media | Target Coverage Analysis | Contact Us | PDI, Inc. |
|